JPRN-UMIN000042107Completed未知
Effects of denosumab on the treatment of osteoporosis and inhibition of bone erosion in rheumatoid arthritis - Evaluation of the Therapeutic Effect of Denosumab on Rheumatoid Arthritis and Osteoporosis
Department of Orthopedic Surgery, Tohoku University Graduate School of Medicine0 sites200 target enrollmentStarted: October 14, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 40years-old to 90years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Use of parathyroid hormones drugs History of bone metabolic disease hypocalcemia
Investigators
Similar Trials
Completed
Not Applicable
The effect of denosumab for the treatment of osteoporosis in hemodialysis patientsOsteoporosisJPRN-UMIN000014458Saiseikai Kumamoto Hospital40
Completed
Not Applicable
Efficacy of denosumab in steroid-induced osteoporosis against insufficient effect by bisphosphonate.OsteoporosisJPRN-UMIN000040533Others50
Completed
Not Applicable
The effect of denosmab on osteoporosis related to Parkinson's disease and glucocorticoid-induced osteoporosisJPRN-UMIN000025056The Jikei University School of Medicine40
Active, not recruiting
Not Applicable
A clinical trial to find out whether a medication, called denosumab, has an effect on the bone surrounding a hip joint replacementEUCTR2011-000541-20-GBSheffield Teaching Hospitals NHS Foundation Trust30
Recruiting
Not Applicable
Effects of denosumab for bone resorption in the femur after total hip arthroplastypatients treated with primary total hip arthroplastyJPRN-UMIN000028169Yokohama City University80